IIEKKING G DOUG

IIEKKING G DOUG, Chief Financial Officer of USANA Health Sciences (USNA), has demonstrated a consistent pattern of selling activity over the past several years, with no recorded purchases in SEC filings. Since 2024, his transactions have exclusively involved dispositions of USNA shares, totaling over $1.01 million in aggregate value. The most significant single sale occurred on May 7, 2024, when he disposed of shares worth $232,676.51. Smaller but repeated sales followed in February 2025 and February 2026, with transactions typically clustered within a narrow window—often between February 6-8—suggesting a structured selling approach. For instance, in February 2026 alone, he executed four sales totaling $108,267.12, $58,599.64, $34,400.08, and $54,779.78. The filings indicate that IIEKKING’s sales are primarily coded as "F" (tax liability or other mandatory transactions) rather than discretionary dispositions, though the May 2024 transaction was marked as an open-market sale ("S"). His activity is concentrated solely in USNA, with no diversification across other securities. The absence of any buy transactions—coupled with the recurring February sales—points to a disciplined, possibly schedule-driven divestment strategy rather than opportunistic trading. The dollar amounts per transaction have varied, ranging from mid-five-figure to low-six-figure sums, without a clear directional trend in sale sizes over time. This pattern aligns with executives managing equity-based compensation, though the filings provide no explicit rationale for the transactions.